Standard Biotools (LAB) Free Cash Flow (QoQ) (2010 - 2026)
Standard Biotools (LAB) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.41% |
| Mar 31, 2026 | -2,361.49% |
| Dec 31, 2025 | 91.40% |
| Sep 30, 2025 | -40.24% |
| Jun 30, 2025 | 55.30% |
| Mar 31, 2025 | -224.19% |
| Dec 31, 2024 | 66.81% |
| Sep 30, 2024 | 14.18% |
| Jun 30, 2024 | 39.50% |
| Mar 31, 2024 | -459.40% |
| Dec 31, 2023 | 8.19% |
| Sep 30, 2023 | -21.15% |
| Jun 30, 2023 | -7.08% |
| Mar 31, 2023 | 52.37% |
| Dec 31, 2022 | 22.95% |
| Sep 30, 2022 | 16.33% |
| Jun 30, 2022 | -87.91% |
| Mar 31, 2022 | -3,191.60% |
| Dec 31, 2021 | 99.00% |
| Sep 30, 2021 | -28.97% |